EAN News

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial

Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial

Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial

Cerebrospinal Fluid Leak After Nasal Swab Testing for Coronavirus Disease 2019

Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders

Postmortem Neuropathology in COVID-19

EAN endorsed meetings in November 2020

Elena Moro interviews Dr. Prashanth LK

Beomseok Jeon, President AOAN interviewed by D. Muresanu

On November´s executive page is Dafin Muresanu who was reelected as Chair of Communication Committee

For November 2020, we have selected: Wang Z. et al. Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease. JAMA Neurol 2020;e203311. doi: 10.1001/jamaneurol.2020.3311. Online ahead of print.

November´s country of the month is Netherlands

EJoN publishes EAN consensus statement for management of patients with neurological diseases during the COVID‐19 pandemic

External Interview: Prof. Dafin Muresanu, Chair of the EAN Communication Committee, interviews Prof. Jean-Antoine Girault, President of FENS – Federation of European Neuroscience Societies